As a part of planned reassessment for the current period, a decision has been made to prioritize, optimize, and reallocate resources. As a result, enrollment and other study activities have been temporarily halted.
Summary
A multicentre observational study on treatment approaches and biomarkers in de novo metastatic hormone sensitive prostate cancer in Russian Federation
Protocol Amendment History
5 amendments
This ClinicalTrials.gov record has been amended 5 times since 2025-08-27; most recent amendment 2026-06-25.